Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Phosphorothioate oligonucleotide targeted to transthyretin

EU orphan designation number: EU/3/14/1250   
Active ingredient: Phosphorothioate oligonucleotide targeted to transthyretin
Indication: Treatment of ATTR amyloidosis
Sponsor: Ionis USA Limited
Tower 42, level 30, International Finance Centre, 25 Old Broad Street, London EC2N 1HQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/03/2014 Orphan designation EMA/OD/098/13 (2014)2108 of 26/03/2014
07/04/2016 Change of name and/or address of sponsor